Atorvastatin Calcium
Product Images NDC 71610-180

6 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71610-180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

71610 0180 15

71610 0180 15
Atorvastatin Calcium 20 mg tablet packaging label showing 15 tablets per container. The label includes storage instructions, manufacturer details (ScieGen Pharmaceuticals Inc), and mentions Aphena Pharma Solutions - Tennessee, LLC as the labeler. It also features the NDC number 71610-0180-15 and typical regulatory information including lot, serial number, and expiration date fields.*
FDA Label Image

Aphena Pharma Solutions (TN)

Aphena Pharma Solutions (TN)
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A cumulative incidence line chart comparing Atorvastatin and placebo over approximately 3.5 years. The x-axis represents years, and the y-axis shows cumulative incidence percentage. The graph shows lower incidence for Atorvastatin versus placebo, with hazard ratio and p-value indicated on the chart.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line chart comparing the cumulative hazard percentages over time for placebo and atorvastatin groups through four years of follow-up. The x-axis represents time in years to the first primary endpoint, and the y-axis shows cumulative hazard percentage. The chart includes a hazard ratio (HR) of 0.63 with a confidence interval of 0.48 to 0.83 and a p-value of 0.001, indicating statistical comparison between treatments.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph depicting the percentage of subjects experiencing a cardiovascular event over five years, comparing Atorvastatin 10 mg and 80 mg dosages. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR 0.78) with confidence intervals and a p-value indicating statistical significance.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of atorvastatin calcium, depicting the molecular arrangement including phenyl rings, fluorophenyl group, and calcium ion associations as shown in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.